Neoplasm Treatment Market Segmentation:
Type (Malignant, Benign)
The global neoplasm treatment market is segmented and analyzed for demand and supply by type into benign, and malignant, out of which, the malignant segment is anticipated to hold the notable share in the global neoplasm treatment market over the forecast period on account of the growing prevalence of malignant, i.e., cancerous neoplasm across the globe. In addition, malignant is a severe kind of neoplasm that usually grow faster than benign and can spread to the whole body of the patient, they are not controlled at the right time, and can invade the nearby tissues. Moreover, the higher exposure to carcinogens, backed by poor lifestyle habits in present times, is estimated to fuel the segment. According to the World Health Organization, cancer accounted for nearly one in six deaths across the globe in the year 2020.
End-user (Specialty Clinics, Hospital, Cancer Research Center)
The global neoplasm treatment market is also segmented and analyzed for demand and supply by end-user into specialty clinics, hospital, cancer research center, and others. Out of these, the hospitals segment is projected to hold the largest share over the forecast period in the global neoplasm treatment market. The growth of the segment can be owing to the increasing number of hospitals around the world for the treatment of diseases. Furthermore, the government invests in hospitals for providing treatment facilities to patients belonging to the lower income category. In addition, they are able to deal with the emergency cases with the advanced technologies, and it is expected to increase the segment’s growth in the market. As per the data reported in 2020, the total number of hospitals in Japan accounted to more than 8,000. In addition, the number of hospitals in Korea has increased to more than 4,000 in the year 2020.
Our in-depth analysis of the global market includes the following segments:
|
By Type |
|
|
By End-User |
|
